These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 31201056)

  • 1. Purification of flavivirus VLPs by a two-step chomatographic process.
    Lima TM; Souza MO; Castilho LR
    Vaccine; 2019 Nov; 37(47):7061-7069. PubMed ID: 31201056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Envelope-Modified Tetravalent Dengue Virus-Like-Particle Vaccine Has Implications for Flavivirus Vaccine Design.
    Urakami A; Ngwe Tun MM; Moi ML; Sakurai A; Ishikawa M; Kuno S; Ueno R; Morita K; Akahata W
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28956764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of Virus-Like-Particle Vaccine and Reporter Assay for Zika Virus.
    Garg H; Sedano M; Plata G; Punke EB; Joshi A
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28794019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunization with phage virus-like particles displaying Zika virus potential B-cell epitopes neutralizes Zika virus infection of monkey kidney cells.
    Basu R; Zhai L; Contreras A; Tumban E
    Vaccine; 2018 Feb; 36(10):1256-1264. PubMed ID: 29395533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zika virus-like particles (VLPs): Stable cell lines and continuous perfusion processes as a new potential vaccine manufacturing platform.
    Alvim RGF; Itabaiana I; Castilho LR
    Vaccine; 2019 Nov; 37(47):6970-6977. PubMed ID: 31164305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A chimeric yellow fever-Zika virus vaccine candidate fully protects against yellow fever virus infection in mice.
    Kum DB; Boudewijns R; Ma J; Mishra N; Schols D; Neyts J; Dallmeier K
    Emerg Microbes Infect; 2020; 9(1):520-533. PubMed ID: 32116148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zika virus-like particle vaccine protects AG129 mice and rhesus macaques against Zika virus.
    Vang L; Morello CS; Mendy J; Thompson D; Manayani D; Guenther B; Julander J; Sanford D; Jain A; Patel A; Shabram P; Smith J; Alexander J
    PLoS Negl Trop Dis; 2021 Mar; 15(3):e0009195. PubMed ID: 33711018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of Flavivirus Cross-Protection against Yellow Fever in a Mouse Model.
    Shinde DP; Walker J; Reyna RA; Scharton D; Mitchell B; Dulaney E; Bonam SR; Hu H; Plante JA; Plante KS; Weaver SC
    Viruses; 2024 May; 16(6):. PubMed ID: 38932129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zika virus like particles elicit protective antibodies in mice.
    Salvo MA; Kingstad-Bakke B; Salas-Quinchucua C; Camacho E; Osorio JE
    PLoS Negl Trop Dis; 2018 Feb; 12(2):e0006210. PubMed ID: 29401460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Vaccine Based on a Modified Vaccinia Virus Ankara Vector Expressing Zika Virus Structural Proteins Controls Zika Virus Replication in Mice.
    Pérez P; Q Marín M; Lázaro-Frías A; Jiménez de Oya N; Blázquez AB; Escribano-Romero E; S Sorzano CÓ; Ortego J; Saiz JC; Esteban M; Martín-Acebes MA; García-Arriaza J
    Sci Rep; 2018 Nov; 8(1):17385. PubMed ID: 30478418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human Schwann cells are susceptible to infection with Zika and yellow fever viruses, but not dengue virus.
    Dhiman G; Abraham R; Griffin DE
    Sci Rep; 2019 Jul; 9(1):9951. PubMed ID: 31289325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zika virus-like particle vaccine fusion loop mutation increases production yield but fails to protect AG129 mice against Zika virus challenge.
    Thompson D; Guenther B; Manayani D; Mendy J; Smith J; Espinosa DA; Harris E; Alexander J; Vang L; Morello CS
    PLoS Negl Trop Dis; 2022 Jul; 16(7):e0010588. PubMed ID: 35793354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virus Like Particles (VLP) as multivalent vaccine candidate against Chikungunya, Japanese Encephalitis, Yellow Fever and Zika Virus.
    Garg H; Mehmetoglu-Gurbuz T; Joshi A
    Sci Rep; 2020 Mar; 10(1):4017. PubMed ID: 32132648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-existing Immunity to Japanese Encephalitis Virus Alters CD4 T Cell Responses to Zika Virus Inactivated Vaccine.
    Lima NS; Moon D; Darko S; De La Barrera RA; Lin L; Koren MA; Jarman RG; Eckels KH; Thomas SJ; Michael NL; Modjarrad K; Douek DC; Trautmann L
    Front Immunol; 2021; 12():640190. PubMed ID: 33717194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zika virus-like particle (VLP) based vaccine.
    Boigard H; Alimova A; Martin GR; Katz A; Gottlieb P; Galarza JM
    PLoS Negl Trop Dis; 2017 May; 11(5):e0005608. PubMed ID: 28481898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping the diverse structural landscape of the flavivirus antibody repertoire.
    Sevvana M; Kuhn RJ
    Curr Opin Virol; 2020 Dec; 45():51-64. PubMed ID: 32801077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chimeric yellow fever 17D-Zika virus (ChimeriVax-Zika) as a live-attenuated Zika virus vaccine.
    Giel-Moloney M; Goncalvez AP; Catalan J; Lecouturier V; Girerd-Chambaz Y; Diaz F; Maldonado-Arocho F; Gomila RC; Bernard MC; Oomen R; Delagrave S; Burdin N; Kleanthous H; Jackson N; Heinrichs J; Pugachev KV
    Sci Rep; 2018 Sep; 8(1):13206. PubMed ID: 30181550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Priming with Japanese encephalitis virus or yellow fever virus vaccination led to the recognition of multiple flaviviruses without boosting antibody responses induced by an inactivated Zika virus vaccine.
    Li Y; Merbah M; Wollen-Roberts S; Beckman B; Mdluli T; Curtis DJ; Currier JR; Mendez-Rivera L; Dussupt V; Krebs SJ; De La Barrera R; Michael NL; Paquin-Proulx D; Eller MA; Koren MA; Modjarrad K; Rolland M
    EBioMedicine; 2023 Nov; 97():104815. PubMed ID: 37793212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Passive Transfer of Immune Sera Induced by a Zika Virus-Like Particle Vaccine Protects AG129 Mice Against Lethal Zika Virus Challenge.
    Espinosa D; Mendy J; Manayani D; Vang L; Wang C; Richard T; Guenther B; Aruri J; Avanzini J; Garduno F; Farness P; Gurwith M; Smith J; Harris E; Alexander J
    EBioMedicine; 2018 Jan; 27():61-70. PubMed ID: 29269041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Process intensification of EB66® cell cultivations leads to high-yield yellow fever and Zika virus production.
    Nikolay A; Léon A; Schwamborn K; Genzel Y; Reichl U
    Appl Microbiol Biotechnol; 2018 Oct; 102(20):8725-8737. PubMed ID: 30091043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.